title: Lamotrigine versus carbamazepine in epilepsy.
authors.forename: X
authors.initials: X
authors.lastname: Duval
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
authors.forename: F
authors.initials: F
authors.lastname: Semah
authors.forename: D
authors.initials: D
authors.lastname: Lipsker
authors.forename: C
authors.initials: C
authors.lastname: Francès
authors.forename: S
authors.initials: S
authors.lastname: Herson
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D004829:Epilepsy, Generalized / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy*; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000209:etiology; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D002998:Clonazepam; D014635:Valproic Acid; D000077213:Lamotrigine